Shuchismita Dutta (@sd_viz) 's Twitter Profile
Shuchismita Dutta

@sd_viz

Science Communicator and Global Health advocate; Storyteller, combining multi-disciplinary perspectives with molecular visualization; AAAS Fellow.

ID: 4418763263

linkhttps://oirap.rutgers.edu/facsurv/html/Shuchismita_Dutta.html calendar_today08-12-2015 19:20:41

948 Tweet

233 Takipçi

81 Takip Edilen

Shuchismita Dutta (@sd_viz) 's Twitter Profile Photo
Shuchismita Dutta
@sd_viz

9 months ago

Tovorafenib, a type II RAF kinase inhibitor was approved by U.S. FDA to treat a type of brain tumour in children - e.g., relapsed or refractory pediatric low-grade glioma esp. with BRAF gene mutations (e.g., V600E). #Cancer #BRAIN

Tovorafenib, a type II RAF kinase inhibitor was approved by <a href="/US_FDA/">U.S. FDA</a> to treat a type of brain tumour in children - e.g., relapsed or refractory pediatric low-grade glioma esp. with BRAF gene mutations (e.g., V600E). #Cancer #BRAIN